Transcriptomics

Dataset Information

0

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-overexpressing solid tumor malignancies


ABSTRACT: 16 patients with HER2+ tumors were enrolled (12 breast, 3 gastric, 1 esophageal). 27 samples (12 primary + 15 metastatic) from the 16 unique patients were assayed on Agilent 60K expression microarrays, and association between expression and response data were evaluated to identify potential biomarker of MK2206 response

ORGANISM(S): Homo sapiens

PROVIDER: GSE75087 | GEO | 2016/07/31

SECONDARY ACCESSION(S): PRJNA302430

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-07-31 | E-GEOD-75087 | biostudies-arrayexpress
| S-EPMC4342675 | biostudies-literature
| S-EPMC3979046 | biostudies-literature
| S-EPMC3884022 | biostudies-literature
| S-EPMC3772348 | biostudies-literature
| S-EPMC3988257 | biostudies-literature
| S-EPMC5654518 | biostudies-literature
| S-EPMC4964088 | biostudies-literature
| S-EPMC4972858 | biostudies-literature
| S-EPMC4791863 | biostudies-literature